Philip Facchina

Non-Executive Director / Mesoblast

Philip Facchina has over 35 years of experience in corporate strategy, finance, and business development across several industries including healthcare.

Since 2018, Mr Facchina has been the chief strategy officer of SurgCenter Development, managing the company's strategic relationships including its relationships with the US ambulatory surgical centers (ASC) market and its constituents.

Prior to SurgCenter, Mr Facchina spent two decades in the public and private capital markets, where he directly managed public and private capital transactions of equity and debt, led M&A and special advisory processes including take-privates.

Lists and Charts

Roles

2021

Non-Executive Director

Mesoblast

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
16^th	Bellavista Resources	400.15%	0%
17^th	Nyrada Inc	399.89%	0%
18^th	Mesoblast	360.92%	0.62%
19^th	Petratherm	360.61%	40.77%
20^th	Chilwa Minerals	357.87%	0%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

NEW ROLE: Non-Executive Director, Mesoblast

13 Apr 2021

Related Information

Access to our data for Philip Facchina is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Philip Facchina is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.